COVID-19 and EVALI: Considerations regarding two concurrent public health crises
Am J Emerg Med
.
2022 Jun:56:389-390.
doi: 10.1016/j.ajem.2021.11.042.
Epub 2021 Dec 3.
Authors
Kathleen M Mulligan
1
,
David X Zheng
2
,
Benjamin Gallo Marin
3
,
Michael T Do
2
,
Dominique L Tucker
2
,
Zenas Igbinoba
4
,
Daniel A Notterman
5
Affiliations
1
Case Western Reserve University School of Medicine, Cleveland, OH, United States of America. Electronic address: kmm334@case.edu.
2
Case Western Reserve University School of Medicine, Cleveland, OH, United States of America.
3
Warren Alpert Medical School, Brown University, Providence, RI, United States of America.
4
Department of Radiology, Columbia University Irving Medical Center, New York, NY, United States of America.
5
Department of Molecular Biology, Princeton University, Princeton, NJ, United States of America.
PMID:
34893400
PMCID:
PMC8641405
DOI:
10.1016/j.ajem.2021.11.042
No abstract available
Publication types
Letter
MeSH terms
COVID-19* / epidemiology
Electronic Nicotine Delivery Systems*
Humans
Lung Injury*
Public Health
Vaping*
Grants and funding
R25 AI140490/AI/NIAID NIH HHS/United States